Statement of Deviation or Variation - Q4 2025-26
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Samsrita Labs Limited has filed a nil-deviation statement for the quarter ended March 31, 2026, regarding Rs. 339.10 Lakhs raised via preferential issue on July 18, 2025. The funds were allocated across four purposes: Working Capital (Rs. 52.10L fully utilized), New Project Investment (Rs. 132.46L allocated, only Rs. 2L deployed), Promoter Loan Repayment (Rs. 88.31L fully utilized), and General Corporate Purpose (Rs. 66.23L allocated, Rs. 34.32L utilized). The Audit Committee reviewed and confirmed no deviation in the intended use of proceeds. Total deployment so far is approximately Rs. 176.73 Lakhs (52% of raised funds), with significant capital still held for project investment.
The company has confirmed proper use of proceeds with no deviation, which is positive from a compliance standpoint. However, the heavy under-utilization of project investment funds (only 1.5% deployed) suggests the company is holding capital for future deployment, which investors may view neutrally.